These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6779312)

  • 21. Preference for fixed vs self-selected durations of brain stimulation in rats administered D-amphetamine sulphate.
    Zacharko RM; Kokkinidis L
    Life Sci; 1982 Mar; 30(12):1029-34. PubMed ID: 7070206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of naloxone to modify the effects of chlorpromazine and d-amphetamine on avoidance behavior in the squirrel monkey.
    Holtzman SG
    Psychopharmacology (Berl); 1979 Jun; 63(3):207-9. PubMed ID: 113805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chronic naloxone treatment on brain-stimulation reward.
    Perry W; Esposito RU; Kornetsky C
    Pharmacol Biochem Behav; 1981 Feb; 14(2):247-9. PubMed ID: 7208563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nicotine on the threshold for rewarding brain stimulation in rats.
    Huston-Lyons D; Kornetsky C
    Pharmacol Biochem Behav; 1992 Apr; 41(4):755-9. PubMed ID: 1594644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats.
    Carr KD; Yamamoto N; Omura M; Cabeza de Vaca S; Krahne L
    Psychopharmacology (Berl); 2002 Aug; 163(1):76-84. PubMed ID: 12185403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of amfonelic acid alone and in combination with naloxone on brain-stimulation reward.
    Knapp CM; Kornetsky C
    Pharmacol Biochem Behav; 1989 Apr; 32(4):977-82. PubMed ID: 2572008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catecholamines and endogenous opioids in ventral tegmental self-stimulation reward.
    van Wolfswinkel L; Seifert WF; van Ree JM
    Pharmacol Biochem Behav; 1988 Jul; 30(3):589-95. PubMed ID: 3211968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of morphine and naloxone on thresholds of ventral tegmental electrical self-stimulation.
    van Wolfswinkel L; van Ree JM
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):84-92. PubMed ID: 4047179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of morphine alone and in combination with naloxone or d-amphetamine on shock-maintained behavior in the squirrel monkey.
    Byrd LD
    Psychopharmacology (Berl); 1976 Sep; 49(3):225-34. PubMed ID: 826938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of naloxone infusion upon spontaneous and amphetamine-induced activity.
    Jones DN; Holtzman SG
    Eur J Pharmacol; 1992 Oct; 221(1):161-5. PubMed ID: 1333971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing the work requirements lowers the threshold of naloxone for reducing self-stimulation in the midbrain of rats.
    West CH; Schaefer GJ; Michael RP
    Pharmacol Biochem Behav; 1983 May; 18(5):705-10. PubMed ID: 6856645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The preferential dopamine autoreceptor antagonist (+)-UH232 antagonizes the positive reinforcing effects of cocaine and d-amphetamine in the ICSS paradigm.
    Kling-Petersen T; Ljung E; Svensson K
    Pharmacol Biochem Behav; 1994 Oct; 49(2):345-51. PubMed ID: 7824548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of repeated amphetamine injections on lateral hypothalamic brain stimulation reward and subsequent locomotion.
    Wise RA; Munn E
    Behav Brain Res; 1993 Jun; 55(2):195-201. PubMed ID: 8357528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of amphetamine isomers on SN self-stimulation: evidence for DA neuron subtypes.
    Franklin KB; Vaccarino FJ
    Pharmacol Biochem Behav; 1983 May; 18(5):747-51. PubMed ID: 6856648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chlorpromazine and brain-stimulation reward: potentiation of effects by naloxone.
    Esposito RU; Perry W; Kornetsky C
    Pharmacol Biochem Behav; 1981 Dec; 15(6):903-5. PubMed ID: 7323115
    [No Abstract]   [Full Text] [Related]  

  • 36. Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds.
    Wise RA; Munn E
    Psychopharmacology (Berl); 1995 Jan; 117(2):130-6. PubMed ID: 7753958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of beta-phenylethylamine and d-amphetamine on electrical self-stimulation of brain.
    Howard JL; Pollard GT; Rohrbach KW; Harto NE
    Pharmacol Biochem Behav; 1976 Dec; 5(6):661-4. PubMed ID: 139616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Threshold differences for naloxone and naltrexone in the hypothalamus and midbrain using fixed ratio brain self-stimulation in rats.
    Schaefer GJ; Michael RP
    Psychopharmacology (Berl); 1981; 74(1):17-22. PubMed ID: 6791198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pentobarbital induces a naloxone-reversible decrease in mesolimbic self-stimulation threshold.
    Seeger TF; Carlson KR; Nazzaro JM
    Pharmacol Biochem Behav; 1981 Oct; 15(4):583-6. PubMed ID: 7291262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-stimulation and amphetamine: tolerance to d and l isomers and cross tolerance to cocaine and methylphenidate.
    Leith NJ; Barrett RJ
    Psychopharmacology (Berl); 1981; 74(1):23-8. PubMed ID: 6791199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.